Jesper Høiland retires as chief commercial officer of Ascendis Pharma
Former executive vice president of Novo Nordisk, US, Jesper Høiland has decided to step down from his role as global chief commercial officer at Ascendis Pharma.
by christopher due karlsson, translated by daniel pedersen
Danish biotech firm Ascendis Pharma, which is publicly listed in the US, has announced that Jesper Høiland, a former long-standing executive at Novo Nordisk in the US, is retiring from his role as global chief commercial officer, the firm reports on Monday.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Ascendis Pharma to raise capital with convertible notes
For subscribers
Ascendis Pharma reports promising phase III data
For subscribers
